AstraZeneca Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,517,775	1,585,274	1,256,595	1,015,431	1,107,234	1,014,241
Market Cap Growth	13.09%	26.16%	23.75%	-8.29%	9.17%	48.79%
Enterprise Value	1,643,542	1,720,733	1,411,241	1,139,326	1,260,280	1,167,385
Last Close Price	163.19	166.97	130.93	102.96	110.81	-
PE Ratio	26.95	28.15	28.88	35.14	63.70	1625.31
PS Ratio	4.69	4.90	3.76	4.57	4.72	4.87
PB Ratio	5.66	5.91	4.97	5.34	5.65	4.63
P/FCF Ratio	23.42	24.46	20.45	23.29	24.03	37.36
P/OCF Ratio	18.91	19.75	17.13	20.23	21.35	30.53
EV/Sales Ratio	5.35	5.32	4.22	5.13	5.38	5.60
EV/EBITDA Ratio	15.96	16.20	12.99	16.45	17.35	31.27
EV/EBIT Ratio	21.99	21.86	17.65	24.21	27.05	72.32
EV/FCF Ratio	25.36	26.55	22.96	26.14	27.35	43.01
Debt / Equity Ratio	0.61	0.61	0.75	0.76	0.84	0.85
Debt / EBITDA Ratio	1.51	1.51	1.70	2.04	2.23	4.81
Debt / FCF Ratio	2.53	2.53	3.07	3.30	3.57	6.85
Net Debt / Equity Ratio	0.49	0.49	0.61	0.61	0.67	0.69
Net Debt / EBITDA Ratio	1.24	1.24	1.42	1.67	1.81	4.02
Net Debt / FCF Ratio	2.04	2.04	2.51	2.65	2.86	5.54
Asset Turnover	0.54	0.54	0.53	0.46	0.44	0.44
Inventory Turnover	1.81	1.81	1.80	1.59	1.26	1.85
Quick Ratio	0.65	0.65	0.67	0.58	0.62	0.67
Current Ratio	0.94	0.94	0.93	0.82	0.86	1.16
Return on Equity (ROE)	22.84%	22.84%	17.59%	15.64%	8.63%	0.42%
Return on Assets (ROA)	8.19%	8.19%	7.88%	6.13%	5.46%	2.10%
Return on Invested Capital (ROIC)	16.48%	17.03%	16.27%	13.42%	13.75%	6.00%
Return on Capital Employed (ROCE)	17.10%	17.10%	17.00%	13.70%	12.60%	3.50%
Earnings Yield	3.71%	3.55%	3.46%	2.85%	1.57%	0.06%
FCF Yield	4.27%	4.09%	4.89%	4.29%	4.16%	2.68%
Dividend Yield	1.64%	10.56%	14.64%	13.67%	13.84%	-
Payout Ratio	47.39%	47.39%	65.47%	75.42%	132.72%	3442.86%
Buyback Yield / Dilution	0.06%	0.06%	-0.06%	-0.13%	-9.32%	-8.68%
Total Shareholder Return	1.70%	10.62%	14.58%	13.54%	4.52%	-8.68%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.